Wednesday, January 24, 2024 9:42:09 AM
NAPLES, FL -- January 24, 2024 -- InvestorsHub NewsWire -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on improving healthcare outcomes through technology, proudly announces the release of the health documentary "Forever: The End of Aging" on Prime Video. Directed by Paul Castro, acclaimed writer of the blockbuster movie "August Rush," this groundbreaking film features HealthLynked and its CEO, Dr. Michael Dent, offering a compelling look at the future of healthcare and the revolutionary role of AI and technology in medical advancements.
Joining Dr. Dent is an esteemed lineup of over 15 medical experts, including Dr. David Perlmutter, a five-time New York Times bestselling author recognized for his insights into neurological health and nutrition. The documentary explores cutting-edge healthcare solutions such as gene therapy, medical information exchange, and the transformative potential of AI in healthcare.
"Forever: The End of Aging," aligned with HealthLynked's mission of driving improved outcomes for all healthcare stakeholders, bridges the gap in healthcare through efficient medical information exchange. Dr. Michael Dent's participation in the film underscores HealthLynked's commitment to leveraging advanced technologies, including AI, to enhance patient care and outcomes, positioning the company at the forefront of the healthcare revolution.
Watch the Film: Prime Video US - Forever: The End of Aging
https://www.amazon.com/forever-aging-David-Perlmutter-M-D/dp/B0CQ3283V3/ref=sr_1_4?crid=14VPIVGYL5N04&keywords=forever+the+end+of+aging&qid=1706035167&sprefix=forever+the+end+of+aging%2Caps%2C122&sr=8-4
Prime Video UK - Forever: The End of Aging
https://www.amazon.co.uk/forever-aging-David-Perlmutter-M-D/dp/B0CQ2ZR1T2/ref=sr_1_6?crid=EQYQG65HBO3Q&keywords=forever+the+end+of+aging&qid=1706035917&sprefix=%2Caps%2C136&sr=8-6
About HealthLynked
HealthLynked Corp. is dedicated to enhancing healthcare by facilitating the efficient exchange of medical information between patients and providers. Our cloud based HealthLynked Network empowers members to actively manage their healthcare, providing a centralized and secure location for their medical data, including medications, allergies, past surgeries, and personal health records.
Healthcare providers in our network benefit from improved patient care and key insights into their practice operations. Additionally, our preferred providers can leverage HealthLynked's marketing tools to engage both patients, ensuring better patient compliance and optimized scheduling. To avail these services, providers need to claim their profiles and complete the necessary steps to become an in-network provider.
For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Facebook, Twitter, Instagram, and LinkedIn.
Forward-Looking Statements & Risk Factors
This press release contains forward-looking statements that are not based on historical facts. These statements, as defined by the Private Securities Litigation Reform Act of 1995, may differ from actual results, performance, or achievements. Forward-looking statements involve inherent risks and uncertainties. We advise against placing undue reliance on these statements, which are current only as of the date of this press release.
We are not obligated to publicly update any forward-looking statements unless required by law. Any updates should not be interpreted as an indication of additional updates on the same or other topics. For a detailed understanding of the risks and uncertainties related to our operations, please refer to the "Risk Factors" in our latest Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission, available at www.sec.gov.
HLYK Contact:
Mike Paisan
Director of Investor Relations
IR@healthlynked.com
+1 (800)-928-7144, ext. 123
https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/93125988/healthlynked-and-ceo-dr-michael-dent-featured-in
Recent HLYK News
- HealthLynked Announces Fourth Quarter and Full Year 2023 Results Highlighted by 70% Reduction in Net Loss for Q4 • InvestorsHub NewsWire • 04/02/2024 12:00:00 PM
- HealthLynked Announces Exciting New Update with HealthLynked 3.2.0 - Transforming Patient-Care Through Innovation • InvestorsHub NewsWire • 03/26/2024 12:00:00 PM
- HealthLynked Corp Announces Chris Hall as New Chief Technology Officer • InvestorsHub NewsWire • 03/19/2024 12:00:00 PM
- HealthLynked Welcomes David Rosal as New Chief Financial Officer • InvestorsHub NewsWire • 03/13/2024 12:00:00 PM
- HealthLynked Welcomes Garrett Gardi to Its Advisory Board • InvestorsHub NewsWire • 02/28/2024 01:00:00 PM
- HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming • InvestorsHub NewsWire • 01/24/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:57:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:05:14 PM
- HealthLynked Unveils Advanced Search Functionality to Improve Patient Care • InvestorsHub NewsWire • 12/13/2023 01:00:00 PM
- HealthLynked Announces Q3 & Year-to-Date 2023 Financial Results, Highlighted by 8% Revenue Growth and Net Income Turnaround • InvestorsHub NewsWire • 11/15/2023 01:00:00 PM
- Introducing the New HealthLynked COVID-19 Tracker: A Comprehensive Tool for the Modern Pandemic Era • InvestorsHub NewsWire • 10/12/2023 12:00:00 PM
- HealthLynked Receives Medicare Shared Savings Net Proceeds from Sale of ACO Health Partners • InvestorsHub NewsWire • 10/09/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:28 PM
- HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
- HealthLynked Achieves Key Milestone with Final $300,000 Payment from Sale of ACO Health Partners • InvestorsHub NewsWire • 09/05/2023 12:00:00 PM
- HealthLynked Announces Steady YoY Revenue Increase for Q2 & H1 2023, Highlighting Significant Net Income Boost • InvestorsHub NewsWire • 08/15/2023 12:21:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:12:45 PM
- HealthLynked Corp. Names Wall Street Veteran Mike Paisan to Strategic Investor Relations Role • InvestorsHub NewsWire • 08/01/2023 12:00:00 PM
- HealthLynked Provides Financial Update • InvestorsHub NewsWire • 06/21/2023 12:00:00 PM
- HealthLynked Unveils Major App Update, Enhancing Personalized Healthcare Experience • InvestorsHub NewsWire • 06/06/2023 12:00:00 PM
- HealthLynked Corp. Announces Appointment of Bill Crupi as Regional Manager of Healthcare Services • InvestorsHub NewsWire • 05/23/2023 12:00:00 PM
- Solid Revenue Growth and Earnings Define HealthLynked's Q1 2023 • InvestorsHub NewsWire • 05/16/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM